pteridines has been researched along with sirolimus in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Martin-Martin, N; McMorrow, T; Ryan, MP; Slattery, C | 1 |
| Astrinidis, A; Cox, AM; Hartley, S; Paladhi, UR; Pichette, B; Valianou, M | 1 |
| Choi, B; Choi, H; Jung, HS; Kang, S; Kim, GJ; Kim, H; Kim, HU | 1 |
3 other study(ies) available for pteridines and sirolimus
| Article | Year |
|---|---|
TGF-β1 mediates sirolimus and cyclosporine A-induced alteration of barrier function in renal epithelial cells via a noncanonical ERK1/2 signaling pathway.
Topics: Animals; Butadienes; Cell Line; Claudin-1; Cyclosporine; Electric Impedance; Enzyme Inhibitors; Epithelial Cells; Gene Expression; Immunosuppressive Agents; Kidney; MAP Kinase Signaling System; Membrane Proteins; Nitriles; Pteridines; Sirolimus; Smad Proteins; Swine; Transforming Growth Factor beta1; Up-Regulation | 2011 |
Pharmacological inhibition of Polo-like kinase 1 (PLK1) by BI-2536 decreases the viability and survival of hamartin and tuberin deficient cells via induction of apoptosis and attenuation of autophagy.
Topics: Animals; Apoptosis; Autophagy; Cell Cycle Proteins; Cell Survival; Clone Cells; Gene Expression Regulation; HeLa Cells; Humans; Mice; Polo-Like Kinase 1; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Pteridines; Sirolimus; Tuberous Sclerosis Complex 1 Protein; Tuberous Sclerosis Complex 2 Protein; Tumor Suppressor Proteins | 2015 |
Fabrication of Nanoreaction Clusters with Dual-Functionalized Protein Cage Nanobuilding Blocks.
Topics: Amino Acid Sequence; Bacterial Proteins; Ligands; Nanostructures; Nanotechnology; Peptides; Protein Multimerization; Pteridines; Sirolimus; Tacrolimus Binding Protein 1A | 2018 |